Latest news
Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026 - markets.businessinsider.commarkets.businessinsider.com · Sat, 08 Aug 2026 14:58:32 GMTRoivant Sciences shifts to commercial biopharma with $4.7B cash, eyeing FDA approval for brepocitinib by 2026 - PluangPluang · Sat, 08 Aug 2026 12:25:35 GMTShell and Tube Internals Market to Reach 158 Index by 2035, Driven by Biopharma Cgmp Standards - IndexBoxIndexBox · Sat, 08 Aug 2026 12:06:23 GMTPolypropylene Packing Internals Market to Reach 160 Index by 2035 on Biopharma Capacity Expansion - IndexBoxIndexBox · Sat, 08 Aug 2026 11:16:18 GMTConnect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 08:15:46 GMTXeris Biopharma (NASDAQ:XERS) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:18:55 GMTImmix Biopharma (NASDAQ:IMMX) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 02:59:24 GMTDRI Healthcare Posts Record Q2 Results, Executes Ekterly Put and Adds Biopharma Experts to Board - TipRanksTipRanks · Fri, 07 Aug 2026 21:50:48 GMT